DR. MICHAEL EDWARD BOZIK, M.D.
Neurology at Wharton St, Pittsburgh, PA
License number
Pennsylvania MD044912E
Category
Neurology
Type
Neurology
Address
Address
2100 Wharton St, Pittsburgh, PA 15203
Phone
(412) 488-1776
(412) 488-8487 (Fax)
(412) 488-8487 (Fax)
Personal information
See more information about MICHAEL EDWARD BOZIK at radaris.comName
Address
Phone
175 Hilltop Dr, Southampton, PA 18966
2653 Center St APT 2, Pittsburgh, PA 15205
401 Woodhaven Dr, Wexford, PA 15090
805 Chestnut St, Donora, PA 15033
175 Hilltop Dr, Southampton, PA 18966
Professional information
President And Ceo Knopp Biosciences
Position:
President and CEO at Knopp Biosciences
Location:
Greater Pittsburgh Area
Industry:
Pharmaceuticals
Work:
Knopp Biosciences
since 2005
-
President and CEO
Bristol-Myers Squibb
1998 - 2004
-
VP, Neuroscience Development
Education:
University of Pittsburgh School of Medicine 1983 - 1987
M.D. University of Notre Dame 1976 - 1980
B.A.
M.D. University of Notre Dame 1976 - 1980
B.A.
Michael Edward Bozik, Pittsburgh PA
Specialties:
Neurology
Work:
Knopp Biosciences LLC
2100 Wharton St, Pittsburgh, PA 15203
2100 Wharton St, Pittsburgh, PA 15203
Education:
University of Pittsburgh(1987)
Dr. Michael E Bozik, Pittsburgh PA - MD (Doctor of Medicine)
Specialties:
Neurology
Address:
2100 Wharton St SUITE 615, Pittsburgh 15203
(412) 488-1776 (Phone), (412) 488-8487 (Fax)
1500 E Medical Center Dr, Ann Arbor 48109
(412) 488-1776 (Phone), (412) 488-8487 (Fax)
1500 E Medical Center Dr, Ann Arbor 48109
Certifications:
Neurology, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Pittsburgh / Main Campus
Graduated: 1987
University of Pittsburgh / Main Campus
Graduated: 1987
Compositions Of R(+) And S(-) Pramipexole And Methods Of Using The Same
US Patent:
2008001, Jan 17, 2008
Filed:
May 16, 2007
Appl. No.:
11/749497
Inventors:
Michael Bozik - Pittsburgh PA, US
Thomas Petzinger - Pittsburgh PA, US
Valentin Gribkoff - Wallingford CT, US
Thomas Petzinger - Pittsburgh PA, US
Valentin Gribkoff - Wallingford CT, US
Assignee:
KNOPP NEUROSCIENCES, INC. - Pittsburgh PA
International Classification:
A61K 9/52, A61K 31/426, A61P 25/16
US Classification:
424457000, 514367000
Abstract:
Compositions of predetermined amounts of R(+) pramipexole and S(−) pramipexole and methods of using the same, including for the treatment and prevention of Parkinson's disease, are provided.
Compositions And Methods Of Using R(+) Pramipexole
US Patent:
2007025, Nov 8, 2007
Filed:
Apr 10, 2007
Appl. No.:
11/733642
Inventors:
Michael Bozik - Pittsburgh PA, US
Gregory Hebrank - Greensburg PA, US
Thomas Petzinger - Pittsburgh PA, US
Gregory Hebrank - Greensburg PA, US
Thomas Petzinger - Pittsburgh PA, US
Assignee:
KNOPP NEUROSCIENCES, INC. - Pittsburgh PA
International Classification:
A61K 31/428
US Classification:
514367000
Abstract:
Pharmaceutical compositions of R(+) pramipexole and methods of using such compositions for the treatment or prevention of diseases associated with or related to mitochondrial dysfunction or increased oxidative stress are disclosed.
Modified Release Formulations Of (6R)-4,5,6,7-Tetrahydro-N6-Propyl-2,6-Benzothiazole-Diamine And Methods Of Using The Same
US Patent:
8524695, Sep 3, 2013
Filed:
Mar 14, 2008
Appl. No.:
12/048890
Inventors:
Michael E. Bozik - Pittsburgh PA, US
Thomas Petzinger, Jr. - Pittsburgh PA, US
Valentin Gribkoff - Wallingford CT, US
Thomas Petzinger, Jr. - Pittsburgh PA, US
Valentin Gribkoff - Wallingford CT, US
Assignee:
Knopp Neurosciences, Inc. - Pittsburgh PA
International Classification:
A01N 43/00, A01N 43/78, A61K 31/33, A61K 31/425
US Classification:
514183, 514367
Abstract:
Modified release pharmaceutical compositions (controlled release, sustained release, and/or extended release) of the R-(+) enantiomer of pramipexole (RPPX) and methods of using such compositions for the treatment of neurodegenerative diseases, or those related to mitochondrial dysfunction or increased oxidative stress are disclosed.
Compositions And Methods Of Using R(+) Pramipexole
US Patent:
2012022, Sep 6, 2012
Filed:
May 9, 2012
Appl. No.:
13/467778
Inventors:
Michael E. Bozik - Pittsburgh PA, US
Gregory T. Hebrank - Greensburg PA, US
Thomas Petzinger, JR. - Pittsburgh PA, US
Gregory T. Hebrank - Greensburg PA, US
Thomas Petzinger, JR. - Pittsburgh PA, US
Assignee:
Knopp Neurosciences Inc. - Pittsburgh PA
International Classification:
A61K 31/428, A61P 29/00, A61P 17/00, A61P 9/00, A61P 27/02, A61P 3/10
US Classification:
514367
Abstract:
Pharmaceutical compositions of R(+) pramipexole and methods of using such compositions for the treatment or prevention of diseases associated with or related to mitochondrial dysfunction or increased oxidative stress are disclosed.
Compositions And Methods For Treating Amyotrophic Lateral Sclerosis
US Patent:
2011000, Jan 13, 2011
Filed:
Jun 21, 2010
Appl. No.:
12/819990
Inventors:
Valentin GRIBKOFF - Wallingford CT, US
Michael E. BOZIK - Pittsburgh PA, US
Michael E. BOZIK - Pittsburgh PA, US
International Classification:
A61K 31/428, A61P 25/00
US Classification:
514367
Abstract:
Pharmaceutical compositions of dexpramipexole and methods of using such compositions for the treatment of ALS are disclosed.
Compositions And Methods For Treating Amyotrophic Lateral Sclerosis
US Patent:
2013024, Sep 19, 2013
Filed:
Dec 20, 2012
Appl. No.:
13/722150
Inventors:
Michael E. Bozik - Pittsburgh PA, US
Assignee:
Knopp Neurosciences, Inc. - Pittsburgh PA
International Classification:
A61K 31/428
US Classification:
514367
Abstract:
Pharmaceutical compositions of dexpramipexole and methods of using such compositions for the treatment of ALS are disclosed.
Compositions And Methods Of Using (R)-Pramipexole
US Patent:
8518926, Aug 27, 2013
Filed:
Dec 14, 2007
Appl. No.:
11/957157
Inventors:
Michael E. Bozik - Pittsburgh PA, US
Thomas Petzinger, Jr. - Pittsburgh PA, US
Valentin Gribkoff - Wallingford CT, US
Thomas Petzinger, Jr. - Pittsburgh PA, US
Valentin Gribkoff - Wallingford CT, US
Assignee:
Knopp Neurosciences, Inc. - Pittsburgh PA
International Classification:
A01N 43/00, A01N 43/78, A61K 31/33, A61K 31/425
US Classification:
514183, 514367
Abstract:
Pharmaceutical compositions of (R)-pramipexole and methods and kits of using such compositions for the treatment of neurodegenerative diseases, or those related to mitochondrial dysfunction or increased oxidative stress are disclosed.